Enovis

Enovis Current Assets

The Current Assets of Enovis (ENOV) as of Oct 15, 2026 is 764.27 M USD. In the previous year, Current Assets was 1.15 B USD — a change of -33.34% (lower).

Current Assets

764.27 MUSD

YoY

-33.34%

Last updated:

Current Assets of Enovis is 2025 764.27 M USD. Current Assets of Enovis was 2024 1.15 B USD. It decreases by -33.34% lower compared to the previous year.

The Enovis Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
2.26 B USD
Jan 1, 2019
1.40 B USD
Jan 1, 2020
1.37 B USD
Jan 1, 2021
2.30 B USD
Jan 1, 2022
795.02 M USD
Jan 1, 2023
896.52 M USD
Jan 1, 2024
1.15 B USD
Jan 1, 2025
764.27 M USD
The Enovis Current Assets history
YEARCurrent AssetsYoY
764.27 MUSD-33.34%
1.15 BUSD+27.88%
896.52 MUSD+12.77%
795.02 MUSD-65.48%
2.30 BUSD+68.64%
1.37 BUSD-2.74%
1.40 BUSD-37.95%
2.26 BUSD+9.34%
2.07 BUSD+15.61%
1.79 BUSD+105.41%
871.60 MUSD-18.57%
1.07 BUSD-3.35%
1.11 BUSD-11.93%
1.26 BUSD+437.96%
233.73 MUSD+32.14%
176.88 MUSD+2.09%
173.26 MUSD+10.06%
157.42 MUSD-22.19%
202.30 MUSD+94.01%
104.28 MUSD+28.21%
81.34 MUSD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enovis Stock analysis

What does Enovis do? Enovis Corp, listed on the stock market with ticker ENOV and ISIN US1940145022, is a health care company headquartered in Wilmington, United States. The company has 7,802 employees and went public on May 8, 2008. Enovis operates within the health care sector, focusing on medical technology and the development of clinically differentiated solutions. The company manufactures and distributes medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. It functions through two operational segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment offers products including rigid bracing, orthopedic soft goods, vascular systems, compression garments, and hot and cold therapy solutions, alongside recovery sciences products such as bone growth stimulators and electrical stimulators for clinical rehabilitation and sports medicine. The Reconstructive segment specializes in knee, hip, shoulder, elbow, foot, ankle, and finger implant products, as well as surgical productivity solutions. Additionally, Enovis provides Novastep, a minimally invasive surgery solution for foot and ankle procedures. The company's website is www.enovis.com. Enovis Corp is engaged in the production and distribution of medical devices aimed at improving patient outcomes through innovative technology and solutions in the health care industry. Enovis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enovis stock

Current Assets of Enovis is 764.27 M USD in 2025.

Current Assets of Enovis changed from 1.15 B USD to 764.27 M USD, representing a -33.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Enovis since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Enovis historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Enovis

All Key Metrics — Enovis